-
4 days ago | 
modernaesthetics.com | E. Victor Ross |Alyssa Adams |Jason Mazda
MNML Aesthetics announced a partnership with ShapeScale to integrate 3D body imaging into its MNML Tone Method, a multi-modality body contouring protocol. The collaboration aims to enhance clinical precision and patient engagement in aesthetic practices, particularly in post-weight-loss body transformation.
The MNML Tone Method was introduced at the Medical Spa Show 2025 (AmSpa).
-
1 week ago | 
modernaesthetics.com | E. Victor Ross |Alyssa Adams |Jason Mazda
Cartessa Aesthetics is expanding its Canadian portfolio with the launch of four new technologies, HELIX, TORO, EVERESSE, and ULTRAFORMER MPT, according to a press release from the manufacturer.
The new devices are expected to give Canadian providers access to some of the most advanced, in-demand tools on the market, backed by global success and proven results.
-
3 weeks ago | 
modernaesthetics.com | E. Victor Ross |Alyssa Adams |Jason Mazda
In the latest episode of MATV News, Dr. Shino Bay Aguilera addresses the importance of the Genesis meeting for advancing regenerative medicine education; Allergan Aesthetics announces faculty for its new AMI Training Centers; and a Swiss skincare line known for its HA fillers is now available to patients in the US.
-
1 month ago | 
modernaesthetics.com | E. Victor Ross |Alyssa Adams |Jason Mazda
The U.S. District Court for the Central District of California has ruled in favor of InMode Ltd., granting a default judgment against multiple DHGate sellers accused of promoting and distributing counterfeit aesthetic medical devices, the company announced in a press release.
In its May 6 decision, the court found the defendants liable for trademark infringement, false designation of origin, and unfair competition under California law.
-
1 month ago | 
modernaesthetics.com | E. Victor Ross |Alyssa Adams |Jason Mazda
Advanced vascular lasers are transforming the treatment of rosacea by targeting its root cause (chronic vascular dilation) rather than just managing inflammation.
At the 2025 American Society for Laser Medicine and Surgery (ASLMS) Annual Meeting in Orlando, Eric Bernstein, MD, Director of the Main Line Center for Laser Surgery in Ardmore, PA, highlighted the growing capabilities of vascular lasers in managing rosacea and other vascular lesions.
-
1 month ago | 
modernaesthetics.com | E. Victor Ross |Alyssa Adams |Jason Mazda
At the 2025 American Society for Laser Medicine and Surgery (ASLMS) Annual Meeting in Orlando, E. Victor Ross, MD, shared insights on the evolving role of fractional lasers in dermatologic practice, highlighting both their advantages and limitations.
Risk, Recovery, and Pigmentation
“Why do we even do fractional lasers versus non-fractional lasers?” Dr. Ross, a dermatologist at Scripps Hospital in San Diego and a leading expert in fractional laser technology posed to the attendees.
-
1 month ago | 
modernaesthetics.com | E. Victor Ross |Alyssa Adams |Jason Mazda
Key Takeaways
Individuals aged 18–39 make up two-thirds of those seeking tattoo removal, with visible areas such as forearms and hands being the most treated. Black ink remains the most commonly removed tattoo pigment. Fitzpatrick Skin Types III and IV predominatd the sample, highlighting the need for protocols for treating different skin types.
-
1 month ago | 
modernaesthetics.com | E. Victor Ross |Alyssa Adams |Jason Mazda
Bausch Health Companies Inc. and its aesthetics division, Solta Medical, have introduced Fraxel FTX™, the latest advancement in laser skin resurfacing, at the American Society for Laser Medicine & Surgery (ASLMS) 2025 Annual Conference in Orlando, FL. The launch marks the beginning of a nationwide rollout to dermatologists, plastic surgeons, and aesthetic practitioners, with plans for global expansion later this year.
-
1 month ago | 
modernaesthetics.com | E. Victor Ross |Alyssa Adams |Jason Mazda
Candela has introduced its latest pulsed dye laser platform, the Vbeam Pro, at the 2025 Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS) in Orlando, Florida.
The new system is FDA-cleared for pediatric use and offers dual-wavelength capabilities for broader dermatologic applications. The debut represents the most substantial update to the company’s vascular laser portfolio in decades, according to a press release from the manufacturer.
-
1 month ago | 
modernaesthetics.com | E. Victor Ross |Alyssa Adams |Jason Mazda
Lumenis Be. Ltd. unveiled the newest edition of its breakthrough dual-wavelength laser hair removal solution, SPLENDOR XTM ahead of the American Society for Laser Medicine and Surgery (ASLMS) Conference. SPLENDOR XTM is powered by Lumenis’ proprietary BLEND X® technology, which is the only FDA-cleared simultaneous dual laser emission of Alexandrite (755nm) and Nd;YAG (1064 nm), enabling providers to customize an optimal blend for each patient needs across a wide range of skin tones and hair types.
